COVID-19 Outbreak-Global Rheumatoid Arthritis Treatment Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 125
Arthritis is a vast term, which includes an umbrella of 100 different types of arthritis, the most common ones being osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), fibromyalgia and....
COVID-19 Outbreak-Global Ostomy Drainage Bags Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 108
Ostomy drainage bags are specialty bags sited outside the patients body for waste collection such as stool, mucus and urine. It is used in conditions such as inflammatory bowel disease,....
COVID-19 Outbreak-Global Animal Wound Care Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 120
Animal wound care involves the use of products that aid in recovery of the damaged tissues and in the healing of the wound. The Animal Wound Care market revenue was xx.xx....
COVID-19 Outbreak-Global Glaucoma and Dry Eye Diseases Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 109
The Glaucoma and Dry Eye Diseases market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19....
COVID-19 Outbreak-Global Blood Plasma Products Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 128
The main function of plasma is to transport blood cells, substances needed to maintain human life activities and waste generated in the body. The Blood Plasma Products market revenue was xx.xx....